(Q33404742)

26 July 2017

title

Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha (English)

1 reference

26 July 2017

1 reference

1 reference

Jing Xu

1

1 reference

26 July 2017

Shufeng Liu

2

1 reference

26 July 2017

Yihui Xu

3

1 reference

26 July 2017

Po Tien

4

1 reference

26 July 2017

Guangxia Gao

5

1 reference

26 July 2017

publication date

29 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

141

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

55-62

1 reference

Hepatitis C virus, the E2 envelope protein, and alpha-interferon resistance

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Efficient initiation of HCV RNA replication in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Type I interferons: expression and signalization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

RNA sequences in the Moloney murine leukemia virus genome bound by the Gag precursor protein in the yeast three-hybrid system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

56 A convenient and rapid cytopathic effect inhibition assay for interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Expression of HCV structural proteins impairs IFN-mediated antiviral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Hepatitis C virus expression suppresses interferon signaling by degrading STAT1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Topology of the Membrane-Associated Hepatitis C Virus Protein NS4B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Inhibition of interferon signaling by dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Antiviral actions of interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Sendai virus C protein physically associates with Stat1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Complex modulation of cell type-specific signaling in response to type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Correlation of amino acid variations within nonstructural 4B protein with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2009.01.001

10.1016/J.VIRUSRES.2009.01.001

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference